Neuroendocrine Tumors of the Esophagus: A Comprehensive Report Detailing Etiology, Diagnostics, and Clinical Management

Background Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms arising from neuroendocrine cells and possessing features of both neuronal and hormone-producing cells. They are usually classified based on their site of origin, grade, and function (hormone-producing versus non-functioning). NETs can develop in multiple organs but are extremely rare in the esophagus due to the limited presence of neuroendocrine cells in this organ. Anatomically, NETs of the esophagus are considered foregut neuroendocrine neoplasms, and their grading and staging follow the general principles applied to other foregut NETs. Methods This case centers around a 42-year-old male with progressive dysphagia, odynophagia, and epigastric pain who underwent EGD with biopsy. After histopathological confirmation of esophageal NET, an esophagectomy with gastric pull-through was performed. This particular case illustrates the unique features of neuroendocrine tumors of the esophagus. It underscores the importance of considering this rare condition in differential diagnoses of patients presenting with atypical esophageal symptoms. Results Histopathological examination of the resected specimen showed a well-defined neuroendocrine tumor. Immunohistochemistry confirmed neuroendocrine origin. The patient presented with vague symptoms first thought to be due to common esophageal disorders. Literature indicates that esophageal NETs typically present with nonspecific symptoms. Diagnosis is often made in advanced stages, and treatments are not well standardized due to the rarity of the pathology. Prognosis is dependent on tumor grade, nodal involvement, and metastatic dissemination. Conclusion Advanced diagnostic techniques have made it possible to diagnose and grade esophageal NETs in their initial stages. EUS is very useful to determine the depth of tumor penetration and regional lymph node status. CT and PET scans are effective for detecting distant metastasis and staging disease. Combining various imaging techniques with immunohistochemical staining/markers (chromogranin A and synaptophysin) provides a holistic approach to diagnose and stage esophageal NETs, differentiate from other malignancies, and aid clinicians in formulating evidence-based treatment strategies. Surgical resection is currently the mainstay for curative therapy in localized tumors. Chemotherapy, radiation, or combined treatments treat advanced disease.